The DOI matches its Crossref record; 65 of the 67 references it cites were found in a registry or an index.
Effects of Testosterone Supplementation on Depressive Symptoms and Sexual Dysfunction in Hypogonadal Men with the Metabolic Syndrome
Abstract
Introduction: Low testosterone levels in men are associated with the metabolic syndrome (MetS) as well as with depressive symptoms, low vitality, and sexual dysfunction. Aim: To assess the effects of testosterone administration on these subjective symptoms, which have not extensively been studied in hypogonadal men with the MetS. Main Outcome Measures: The Beck Depression Inventory (BDI-IA), Aging Males’ Symptoms (AMS) scale, and International Index of Erectile Function 5-item (IIEF-5) scale at baseline, 18 and 30 weeks were analysed using multilevel analysis. Methods: In a randomized, placebo-controlled, double-blind, phase III trial (ClinicalTrials.gov identifier: NCT00696748), 184 men suffering from both the MetS and hypogonadism were included. They were treated for 30 weeks with either parenteral testosterone undecanoate (TU; 1,000 mg IM TU, at baseline, and after 6 and 18 weeks; Nebido®) or placebo injections, 105 (92.9%) men receiving TU and 65 (91.5%) receiving placebo completed the 30-week trial. Results: The 184 men were aged mean 52.1 years old (standard deviation [SD] 9.6; range 35–69), with a mean body mass index of 35.5 kg/m2 (SD 6.7; range 25.1–54.8), and a mean total testosterone level of 8.0 nmol/L (SD 4.0). There were significant improvements in BDI-IA (mean difference vs. placebo after 30 weeks: −2.5 points; 95% confidence interval [CI]: −0.9; −4.1; P = 0.003), AMS (−7.4 points; 95% CI: −4.3; −10.5; P <0.001), and IIEF-5 (+3.1 points; 95% CI: +1.8; +4.4; P <0.001). The effects on the BDI-IA, AMS, and IIEF-5 were strongest in men with baseline total testosterone levels <7.7 mmol/L (i.e., median value). Conclusions: TU administration may improve depressive symptoms, aging male symptoms and sexual dysfunction in hypogonadal men with the MetS. The beneficial effects of testosterone were most evident in men with the lowest baseline total testosterone levels.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Effects on depressive mood become detectable after 3–6 weeks with a maximum after 18–30 weeks.”
From Onset of effects of testosterone treatment and time span until maximum effects are achieved (2011) · cites this paper as [79]
In the citing paper
“It is remarkable that effects were more pronounced in men with the lowest baseline testosterone levels (79).”
From Onset of effects of testosterone treatment and time span until maximum effects are achieved (2011) · cites this paper as [79]
In the citing paper
“It is very likely that the positive effects of testosterone on depressive symptoms start as early as after 3–6 weeks, but will most likely take 18–30 weeks to find the patient with a significant improvement.”
From Onset of effects of testosterone treatment and time span until maximum effects are achieved (2011) · cites this paper as [79]
Citations
Cites
Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., Gordon, D. J., Krauss, R. M., Savage, P. J., Smith, S. C., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.169404 · Cited by 11,961
Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation
Beck, A. T., Steer, R. A., & Carbin, M. G. (1988) · Clinical Psychology Review · doi:10.1016/0272-7358(88)90050-5 · Cited by 11,696
The metabolic syndrome—a new worldwide definition
Alberti, K. G. M., Zimmet, P., & Shaw, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67402-8 · Cited by 9,352
Eckel, R. H., Alberti, K., Grundy, S. M., & Zimmet, P. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61794-3 · Cited by 6,317
Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients
Beck, A. T., Steer, R. A., Ball, R., & Ranieri, W. F. (1996) · Journal of Personality Assessment · doi:10.1207/s15327752jpa6703_13 · Cited by 5,965
Rosen, R. C., Riley, A., Wagner, G., Osterloh, I. H., Kirkpatrick, J., & Mishra, A. (1997) · Urology · doi:10.1016/s0090-4295(97)00238-0 · Cited by 5,849
A Critical Evaluation of Simple Methods for the Estimation of Free Testosterone in Serum
Vermeulen, A., Verdonck, L., & Kaufman, J. M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.6079 · Cited by 3,824
Rosen, R., Cappelleri, J. C., Smith, M., Lipsky, J., & Peña, B. (1999) · International Journal of Impotence Research · doi:10.1038/sj.ijir.3900472 · Cited by 3,095
Obesity and Diabetes in the Developing World — A Growing Challenge
Hossain, P., Kawar, B., & El Nahas, M. (2007) · New England Journal of Medicine · doi:10.1056/nejmp068177 · Cited by 2,200
Grundy, S. M., Cleeman, J. I., Daniels, S. R., Donato, K. A., Eckel, R. H., Franklin, B. A., Gordon, D. J., Krauss, R. M., Savage, P. J., Smith, S. C., et al. (2005) · Cardiology in Review · doi:10.1097/01.crd.0000380842.14048.7e · Cited by 1,600
Cited by
Sorted by citations
Items 101–141 of 141
Androgen replacement therapy in men: current evidence and controversy
Barbosa, J. A. B. A., & Cury, J. (2018) · Revista de Medicina · doi:10.11606/issn.1679-9836.v97i3p295-300 · Cited by 6
Clinical significance of androgen secretion disorders in men with a malignancy
Wiechno, P., Poniatowska, G., Michalski, W., Kucharz, J., Sadowska, M., Jońska‐Gmyrek, J., Nietupski, K., Rzymowska, J., & Demkow, T. (2017) · Medical Oncology · doi:10.1007/s12032-017-0982-6 · Cited by 5
Tomar, G., Singh, M., Sharma, I., Nautiyal, A., Aggarwal, S., Chandra, S., Chitme, H. R., Medeiros, C. R., Lima, M. D. A., de Lima, L. R., et al. (2024) · Clinical Traditional Medicine and Pharmacology · doi:10.1016/j.ctmp.2024.200167 · Cited by 3
Obstructive sleep apnea syndrome and age-related hypohonadism
Михайловна, М. И., Berdina, O. N., Semenova, N. V., Madaev, V. V., Рычкова, Л. В., & Колесникова, Л. И. (2017) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro20171174279-83 · Cited by 4
Ramachandran, P., Zitzmann, M., König, C. S., Mulhern, J., Ramachandran, S., & Hackett, G. I. (2024) · Exploration of Endocrine and Metabolic Diseases · doi:10.37349/eemd.2024.00015 · Cited by 3
Dimitriadis, F., & Sofikitis, N. (2014) · Asian Journal of Andrology · doi:10.4103/1008-682x.140967 · Cited by 3
Mel'nichenko, G. A., Shestakova, M. V., Rozhivanov, R. V., Терехова, А. Л., Zilov, A. V., Ladygina, D. O., & Курбатов, Д. Г. (2016) · Diabetes Mellitus · doi:10.14341/7884 · Cited by 2
Kühl, H., & Wiegratz, I. (2017) · Gynäkologische Endokrinologie · doi:10.1007/s10304-017-0126-2 · Cited by 2
Obstructive Sleep Apnea Syndrome and Age-Related Hypogonadism
Михайловна, М. И., Berdina, O. N., Semenova, N. V., Madaev, V. V., Рычкова, Л. В., & Колесникова, Л. И. (2018) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-018-0693-2 · Cited by 2
Shores, M. M. (2020) · Springer eBooks · doi:10.1007/978-3-030-54482-9_12 · Cited by 2
Abonizio, I. T., Dourado, S. R. C., Sousa, T. C., Ricardo, M. L. S., Carmona, W. R., & Mendes, L. D. O. (2022) · Research Society and Development · doi:10.33448/rsd-v11i7.29772 · Cited by 1
Impact of Testosterone Deficiency and Testosterone Therapy on Men’s Health
Traish, A. M. (2025) · Springer eBooks · doi:10.1007/978-3-031-89650-7_13 · Cited by 1
Ask the Expert: Sexual Dysfunction Medication, Hormones, and Nutrition
Bartlik, B. D. (2010) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/foc.8.4.foc547 · Cited by 1
Mannelijk hypogonadisme, een update
Leliefeld, H. H. J., & Dohle, G. R. (2018) · Tijdschrift voor Urologie · doi:10.1007/s13629-018-0235-2 · Cited by 1
Muritala, H. F., & Bewaji, C. O. (2021) · Nigerian Journal of Pure and Applied Sciences · doi:10.48198/njpas/19.a11 · Cited by 1
Differences in male climacteric symptoms with aging among rotating night shift workers
Kubo, S., Yasui, T., Matsuura, Y., & Tomotake, M. (2019) · The Aging Male · doi:10.1080/13685538.2019.1650264 · Cited by 1
Age-Related Testosterone Deficiency Merits Treatment
Traish, A. M. (2021) · Androgens Clinical Research and Therapeutics · doi:10.1089/andro.2020.0019 · Cited by 2
Hackett, G. I. (2017) · Wiley eBooks · doi:10.1002/9781118954621.ch13 · Cited by 1
The Institute of Medicine White Paper on Testosterone: Current Perspective
Donatucci, C. F. (2012) · Humana Press eBooks · doi:10.1007/978-1-62703-179-0_1
Testosterone Undecanoate: A Review
Lyngdorf, P. (2012) · Aging Health · doi:10.2217/ahe.12.26
Elliott, J. (2016) · uO Research (University of Ottawa) · doi:10.20381/ruor-5176
Gianatti, E. (2016) · Minerva Access (University of Melbourne)
Huerta, L. L. (2015) · Gredos (University of Salamanca) · doi:10.14201/gredos.128169
Causas y consecuencias del hipogonadismo en varones con diabetes mellitus tipo 2
Ruiz, A. H. (2015) · Gredos (University of Salamanca) · doi:10.14201/gredos.128430
Fui, M. N. T., & Mark, A. (2017) · Minerva Access (University of Melbourne)
Pharmacosexology: Psychiatric Side Effects of Drugs for the Treatment of Sexual Dysfunction
Abdo, C. H. N. (2018) · Trends in andrology and sexual medicine · doi:10.1007/978-3-319-68306-5_20
Influence of testosterone Drugs Use on Surgical treatment of Acute infectious Pulmonary Destructions
Petukhov, V. I., Ермашкевич, С. Н., Сачек, М. Г., & Кунцевич, М. В. (2020) · Novosti hirurgii · doi:10.18484/2305-0047.2020.1.5
Saad, F. (2022) · Springer eBooks · doi:10.1007/978-3-662-61417-4_9
Self-citation(2011) · Current Opinion in Urology · doi:10.1097/mou.0b013e32834c87d0
Faculty Opinions recommendation of Treatment of men for "low testosterone": A systematic review.
Minhas, S., Tharakan, T., & Miah, S. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.726764636.793556540
The Role of Post-Radical Prostatectomy Testosterone Therapy in Erectile Function Recovery
Huynh, L. M., Gevorkyan, R., & Ahlering, T. E. (2022) · Androgens Clinical Research and Therapeutics · doi:10.1089/andro.2022.0005
Benefits of Testosterone Therapy on Mood and Well-Being
Zitzmann, M. (2025) · Springer eBooks · doi:10.1007/978-3-031-89650-7_22
Testosterone Deficiency Syndrome
Meryn, S. (2014) · Springer eBooks · doi:10.1007/978-3-662-45018-5_10
Yang, L., He, X., Wang, S., Li, T., Huang, W., & Feng, Q. (2026) · The Journal of Sexual Medicine · doi:10.1093/jsxmed/qdag272
Update on testosterone deficiency and therapeutic options for testosterone replacement therapy
Thompson, T., Mubarak, M., Jones, T. H., Pearce, I., & Modgil, V. (2026) · Nature Reviews Urology · doi:10.1038/s41585-026-01190-3
Metadata
- Authors
- Giltay, E. J., Tishova, Y. A., Mskhalaya, G. J., Gooren, L. J. G., Saad, F., & Kalinchenko, S. Y.
- Affiliations
- Leiden University Medical Center (NL)
- Peoples' Friendship University of Russia (RU)
- Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
- Gulf Medical University (AE)
- Corresponding author
- Giltay, Erik J.
- Venue
- The Journal of Sexual Medicine
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-07-01
- Volume
- 7
- Issue
- 7
- Pages
- 2572-2582
- ISSN
- 1743-6095 (ISSN-L)
- 1743-6109
- OpenAlex
- W1706522822
- Cited by
- 140
- References
- 67
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 8 · 2022: 10 · 2021: 6 · 2020: 4 · 2019: 8 · 2018: 9 · 2017: 11 · 2016: 19 · 2015: 11 · 2014: 13 · 2013: 12 · 2012: 9
- FWCI
- 8.47
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- The Journal of Sexual Medicine (publishedVersion)
- PubMed (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Leiden Repository (Leiden University) (submittedVersion)
- Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam) (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Psychiatry and Mental health › Sexual function and dysfunction studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- testosterone undecanoate, testosterone supplementation, hypogonadism, metabolic syndrome, depressive symptoms, sexual dysfunction, erectile function, aging male symptoms, androgen deficiency, men's health, low energy, lack of motivation, low self-esteem, low self-confidence
- MeSH terms
- Adult, Age Factors, Aged, Aging, Androgens, Antidepressive Agents, Depression, Double-Blind Method, Humans, Hypogonadism, Infusions, Intravenous, Infusions, Parenteral, Male, Middle Aged, Psychometrics, Psychotropic Drugs, Surveys and Questionnaires, Regression Analysis, Statistics as Topic, Testosterone, Multivariate Analysis, Confidence Intervals, Statistics, Nonparametric, Metabolic Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
